Revenue from Contracts with Customers - Additional Information (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended			12 Months Ended
	Nov. 30, 2022	Oct. 31, 2022	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation Of Revenue [Line Items]
Royalty revenue						$ 1,557,632	$ 1,663,405	$ 1,111,795
Janssen Pharmaceutica N.V.
Disaggregation Of Revenue [Line Items]
Royalty revenue related to back royalties							195,400
Back royalties late payment interest							8,100
Long-Acting INVEGA Products
Disaggregation Of Revenue [Line Items]
Royalty revenue							486,100	115,700
Royalty revenue recognized							290,700
Royalty
Disaggregation Of Revenue [Line Items]
Royalty revenue						354,669	600,890	219,609
Royalty \| AMPYRA
Disaggregation Of Revenue [Line Items]
Royalty revenue		$ 16,500		$ (3,200)	$ 3,200
Additional award paid	$ 1,800
Arbitration award amount paid			$ 18,300
Repayment of royalty revenue				$ 18,300
Royalty \| Long-Acting INVEGA Products
Disaggregation Of Revenue [Line Items]
Royalty revenue						$ 236,386	$ 486,101	$ 115,655